Dossier
CEPI
Coverage of CEPI in the Nexus archive.
- Moderna is testing its first mRNA Ebola vaccine as the Congo outbreak worsens
Moderna is testing its first mRNA Ebola vaccine with funding from CEPI as the Ebola outbreak in the Congo surpasses 3,700 confirmed cases and 1,600 deaths.
- CEPI begins first human trial of Bundibugyo Ebola vaccine
CEPI has initiated the first human trial of the Bundibugyo Ebola vaccine, named BD-Ebov, to assess its safety and ability to trigger immune responses in healthy adult volunteers.
- CEPI invests $1.9m to accelerate Ebola Vaccine development
CEPI has invested $1.9 million to accelerate the development of an Ebola vaccine. The Bundibugyo outbreak has caused over 560 confirmed infections and more than 100 confirmed deaths.